Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acquistion, add, altogether, antitumor, ASC, ashton, basket, BlackRock, carryforward, choice, choose, Conference, counter, debarment, defense, deficit, diligence, discharged, distributor, doxorubicin, entail, exonerated, expedite, FCA, feedback, foot, footnote, gather, GCP, GMT, hardware, hematopietic, immunotherapy, interact, kinase, Korean, licensor, lot, misappropriation, misconduct, notify, official, OncoVenture, overseeing, owner, PCAOB, persisted, perspective, PK, poor, POZITINIB, preclude, pretax, provisional, provoked, punishable, qui, recast, repayment, reset, rounding, SAB, scrutinized, speak, specialty, suitable, Sunshine, supersede, tam, taxation, taxpayer, tied, timeline, top, turgeon, tyrosine, unlimited, unmanaged, whistleblower, william, xv
Removed:
Acorda, activated, alkylating, amortizable, attracting, augment, Auxilium, Besner, bound, Brett, carryback, Christopher, Clark, closely, collusion, compensatory, complaint, complement, consolidating, County, dedication, defendant, detected, effected, eliminating, enzymatically, estimating, feature, fiduciary, Fik, Hardik, indirect, indoloquinone, ineffective, ineligible, input, integration, Joel, John, Kakadia, Keller, Kenneth, materiality, minimizing, Muenchhagen, Obama, offered, override, overstated, Perry, plaintiff, pollution, purported, purportedly, qualitatively, quantitatively, reacquire, reauthorized, recur, redundant, refinance, reinstated, release, remediated, restitution, roll, SciClone, Scott, selective, Servicing, slightly, stayed, Stefan, sublicense, sunset, Timothy, wholly, write
Filing tables
Filing exhibits
Related press release
Associated SPPI transcripts
SPPI similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-37585, 333-52331, 333-73009, 333-92855, 333-37180, 333-38710, 333-42852, 333-51388, 333-60966, 333-64432, 333-64444, 333-102587, 333-105814, 333-108658, 333-110103, 333-115759, 333-121612, 333-125208, 333-135029, 333-142628, 333-150260, 333-190413, 333-194823, and 333-208760 on Form S‑3, and Registration Statement Nos. 333-30345, 333-54246, 333-106427, 333-119833, 333-134566, 333-160312, 333-160705, 333-164014, 333-176681, 333-202761 and 333-216692 on Form S‑8 of our reports dated March 7, 2018, relating to the consolidated financial statements and financial statement schedule of Spectrum Pharmaceuticals, Inc., and the effectiveness of Spectrum Pharmaceuticals, Inc.’s internal control over financial reporting, appearing in this Annual Report on Form 10‑K of Spectrum Pharmaceuticals, Inc. for the year ended December 31, 2017.
/s/ Deloitte & Touche LLP
Costa Mesa, California
March 7, 2018